PATENT CLAIM ANALYSIS

Application Number: 16151597
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "089000"]

Abstract:
Compounds of formula (I) wherein: Ak 1  represents an alkyl chain, X represents —(CH 2 ) m —, —CH(R)—, —N(R)—, —CH 2 —N(R)—, N(R)—CH 2 — or —CH 2 —N(R)—CH 2 —,      m and R are as defined in the description,       R 1  and R 2  each represent H when X represents —(CH 2 ) m —, —CH(R)—, —N(R)—, —CH 2 —N(R)— or —N(R)—CH 2 —, or together form a bond when X represents —CH 2 —N(R)—CH 2 —, R 3  represents NH 2 , Cy-NH 2 , Cy-Ak 3 -NH 2  or piperidin-4-yl,      Cy and Ak 3  are as defined in the description,       R 4  and R 5 , which may be identical or different, each represent H or F, their optical isomers, and addition salts thereof with a pharmaceutically acceptable acid.  Medicinal products containing the same which are useful in treating conditions requiring a TAFIa inhibitor.

Claim (Index 3):
The method according to  claim 1 , wherein the compound of formula (I) is a compound of formula (Ia): to wherein Ra represents \u2014CH 2 -Ar 1  or \u2014CH 2 -Ar 1 -Ar 2 , wherein Ar 1  and Ar 2 , which may be identical or different, each represent an aryl or heteroaryl group.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 97.0
- Lexical Diversity: 2.81579
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15548533', '12803405', '12291485', '11395747', '12809555']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.753317261940681
- 35 USC 102 Novelty (BERT): 0.6468404055645098
- Combined Prediction Score: 0.7426695763030638
- Mean Citation Score: 367.18251
- Max Citation Score: 616.3701
- Similarity Product: 566.0508175179721

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test